MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202517060301 A) filed by Valar Labs, Inc., Palo Alto, U.S.A., on June 24, for 'predicting patient outcomes related to pancreatic cancer.'
Inventor(s) include Joshi, Anirudh, Rajiv; Vrabac, Damir; Krishna, Viswesh; Krishna, Vrishab; Nimgaonkar, Vivek, Uday; and Tiu, Ekin.
The application for the patent was published on Oct. 10, under issue no. 41/2025.
According to the abstract released by the Intellectual Property India: "Disclosed are systems and methods for an artificial intelligence based pathology platform that can provide prognostic value to clinicians. For example, the platform can predict outcomes related to a pancreatic cancer, and may include the steps of obtaining a histological sample of a pancreatic cancer tumor of a patient, determining a feature set for the histological sample by applying a deep learning module trained on a population of histological samples of cancer tumors of the same type as the obtained histological sample of the cancer tumor, and generating an outcome set for the patient by applying a second model to the determined feature set. Additional methods for identifying a signature for a histological sample that is indicative of treatment outcome are disclosed."
The patent application was internationally filed on Nov. 09, 2023, under International application No.PCT/US2023/079259.
Disclaimer: Curated by HT Syndication.
